970 related articles for article (PubMed ID: 30946828)
1. Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments.
Duman RS; Sanacora G; Krystal JH
Neuron; 2019 Apr; 102(1):75-90. PubMed ID: 30946828
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of neuregulin 1-ErbB4 signaling in parvalbumin interneurons in the rat brain may contribute to the antidepressant properties of ketamine.
Wang N; Zhang GF; Liu XY; Sun HL; Wang XM; Qiu LL; Yang C; Yang JJ
J Mol Neurosci; 2014; 54(2):211-8. PubMed ID: 24633675
[TBL] [Abstract][Full Text] [Related]
3. Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.
Kokane SS; Armant RJ; Bolaños-Guzmán CA; Perrotti LI
Behav Brain Res; 2020 Apr; 384():112548. PubMed ID: 32061748
[TBL] [Abstract][Full Text] [Related]
4. Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine.
Lener MS; Niciu MJ; Ballard ED; Park M; Park LT; Nugent AC; Zarate CA
Biol Psychiatry; 2017 May; 81(10):886-897. PubMed ID: 27449797
[TBL] [Abstract][Full Text] [Related]
5. Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition.
Miller OH; Moran JT; Hall BJ
Neuropharmacology; 2016 Jan; 100():17-26. PubMed ID: 26211972
[TBL] [Abstract][Full Text] [Related]
6. Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies.
Pham TH; Gardier AM
Pharmacol Ther; 2019 Jul; 199():58-90. PubMed ID: 30851296
[TBL] [Abstract][Full Text] [Related]
7. Cortical functional hyperconnectivity in a mouse model of depression and selective network effects of ketamine.
McGirr A; LeDue J; Chan AW; Xie Y; Murphy TH
Brain; 2017 Aug; 140(8):2210-2225. PubMed ID: 28899017
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin-Positive Gamma-Aminobutyric Acid Interneuron Deficits in Depression: Cortical Microcircuit and Therapeutic Perspectives.
Fee C; Banasr M; Sibille E
Biol Psychiatry; 2017 Oct; 82(8):549-559. PubMed ID: 28697889
[TBL] [Abstract][Full Text] [Related]
9. Regional distribution of serotonergic receptors: a systems neuroscience perspective on the downstream effects of the multimodal-acting antidepressant vortioxetine on excitatory and inhibitory neurotransmission.
Pehrson AL; Jeyarajah T; Sanchez C
CNS Spectr; 2016 Apr; 21(2):162-83. PubMed ID: 26250622
[TBL] [Abstract][Full Text] [Related]
10. Dysfunctional glutamatergic and γ-aminobutyric acidergic activities in prefrontal cortex of mice in social defeat model of depression.
Veeraiah P; Noronha JM; Maitra S; Bagga P; Khandelwal N; Chakravarty S; Kumar A; Patel AB
Biol Psychiatry; 2014 Aug; 76(3):231-8. PubMed ID: 24239130
[TBL] [Abstract][Full Text] [Related]
11. Hypothalamic Glutamate/GABA Cotransmission Modulates Hippocampal Circuits and Supports Long-Term Potentiation.
Ajibola MI; Wu JW; Abdulmajeed WI; Lien CC
J Neurosci; 2021 Sep; 41(39):8181-8196. PubMed ID: 34380766
[TBL] [Abstract][Full Text] [Related]
12. Neurobiology of stress, depression, and rapid acting antidepressants: remodeling synaptic connections.
Duman RS
Depress Anxiety; 2014 Apr; 31(4):291-6. PubMed ID: 24616149
[TBL] [Abstract][Full Text] [Related]
13. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders.
Sanacora G; Treccani G; Popoli M
Neuropharmacology; 2012 Jan; 62(1):63-77. PubMed ID: 21827775
[TBL] [Abstract][Full Text] [Related]
14. Is subcortical-cortical midline activity in depression mediated by glutamate and GABA? A cross-species translational approach.
Alcaro A; Panksepp J; Witczak J; Hayes DJ; Northoff G
Neurosci Biobehav Rev; 2010 Mar; 34(4):592-605. PubMed ID: 19958790
[TBL] [Abstract][Full Text] [Related]
15. Influence of glutamate and GABA transport on brain excitatory/inhibitory balance.
Sears SM; Hewett SJ
Exp Biol Med (Maywood); 2021 May; 246(9):1069-1083. PubMed ID: 33554649
[TBL] [Abstract][Full Text] [Related]
16. Chronic noise stress-induced alterations of glutamate and gamma-aminobutyric acid and their metabolism in the rat brain.
Kazi AI; Oommen A
Noise Health; 2014; 16(73):343-9. PubMed ID: 25387529
[TBL] [Abstract][Full Text] [Related]
17. Behavioral effects of toll-like receptor-4 antagonist 'eritoran' in an experimental model of depression: role of prefrontal and hippocampal neurogenesis and γ-aminobutyric acid/glutamate balance.
Aboul-Fotouh S; Habib M; Asaad T; Kassim SK; Ghanem MH
Behav Pharmacol; 2018 Aug; 29(5):413-425. PubMed ID: 29561292
[TBL] [Abstract][Full Text] [Related]
18. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression.
Sanacora G; Gueorguieva R; Epperson CN; Wu YT; Appel M; Rothman DL; Krystal JH; Mason GF
Arch Gen Psychiatry; 2004 Jul; 61(7):705-13. PubMed ID: 15237082
[TBL] [Abstract][Full Text] [Related]
19. GABA and glutamate systems as therapeutic targets in depression and mood disorders.
Kendell SF; Krystal JH; Sanacora G
Expert Opin Ther Targets; 2005 Feb; 9(1):153-68. PubMed ID: 15757488
[TBL] [Abstract][Full Text] [Related]
20. [Ketamine: a neuropsychotropic drug with an innovative mechanism of action].
Guilloux JP; Nguyen TML; Gardier AM
Biol Aujourdhui; 2023; 217(3-4):133-144. PubMed ID: 38018940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
